GABLES CAPITAL MANAGEMENT INC. – Catalyst Pharmaceuticals, Inc. Transaction History
GABLES CAPITAL MANAGEMENT INC. portfolio value:
$5.56M
portfolio value
GABLES CAPITAL MANAGEMENT INC. quarter portfolio value change:
+83.02%
quarter
Catalyst Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.45% | -1.95K shares | 2.51M | $12.83 | 433.81K |
| Q2 2022 | share | Decrease | -0.68% | -3K shares | -582K | $7.01 | 435.76K |
| Q1 2022 | share | Decrease | -2.32% | -10.4K shares | 596K | $8.29 | 438.76K |
| Q4 2021 | share | Increase | +14.71% | 57.6K shares | 966K | $6.89 | 449.16K |
| Q3 2021 | share | Increase | +14.50% | 49.6K shares | 109K | $5.3 | 391.56K |
| Q2 2021 | share | Decrease | -15.99% | -65.1K shares | 89K | $5.75 | 341.96K |
| Q1 2021 | share | Decrease | -1.52% | -6.3K shares | 496K | $4.61 | 407.06K |
| Q4 2020 | share | Decrease | -4.50% | -19.5K shares | 95K | $3.34 | 413.36K |
| Q3 2020 | share | Decrease | -14.60% | -74K shares | -1.05M | $2.97 | 432.86K |
| Q2 2020 | share | Decrease | -1.17% | -6K shares | 363K | $4.62 | 506.86K |
| Q1 2020 | share | Decrease | -0.97% | -5K shares | 35K | $3.85 | 512.86K |
| Q4 2019 | share | Increase | +5.57% | 27.3K shares | -662K | $3.75 | 517.86K |
| Q3 2019 | share | Increase | +0.93% | 4.5K shares | 737K | $5.31 | 490.56K |
| Q2 2019 | share | Increase | +1.31% | 6.3K shares | -580K | $3.84 | 486.06K |
| Q1 2019 | share | Decrease | -0.21% | -1K shares | 1.52M | $5.1 | 479.76K |
| Q4 2018 | share | Increase | +7.25% | 32.5K shares | -771K | $1.92 | 480.76K |
| Q3 2018 | share | Increase | +0.67% | 3K shares | 188K | $3.78 | 448.26K |
| Q2 2018 | share | Decrease | -2.96% | -13.6K shares | 409K | $3.12 | 445.26K |
| Q1 2018 | share | Increase | 0.00% | 458.86K shares | 1.09M | $2.39 | 458.86K |